GABA-modulating treatments could help tackle cognitive, affective symptoms associated with depression

Depression is a complex condition correlated with multiple differences in brain function and mechanisms. A new paper spanning known data about the neurotransmitter GABA and its principal receptors showcases evidence of the receptors' importance in depression and potential as therapeutic targets.

Related Keywords

Toronto ,Ontario ,Canada ,Illinois ,United States ,University School ,University Of Illinois ,Bernhard Luscher ,Megan Craig ,Etienne Sibille ,Uwe Rudolph ,Jamie Maguire ,Mental Health ,Tufts University School Of Medicine ,Tufts University ,University Of Illinois Urbana Champaign ,University Of Toronto ,Centre For Addiction ,Penn State University ,Trends In Pharmacological Sciences ,Illinois Urbana Champaign ,Major Depressive ,Tufts University School ,Brain ,Depression ,Addiction ,Lzheimer 39s Disease ,Antidepressant ,Hronic ,Depressive Disorder ,Drugs ,Eurons ,Pharmaceuticals ,Eceptor ,Research ,Erotonin ,Stress ,